StockData
SELLAS Life Sciences Group, Inc. logo

SELLAS Life Sciences Group, Inc. (SLS) stock

SLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$17.95−1.20 (-6.27%)

Close on Nov 18, 2026Market cap $3.62BP/E –Yield –

SELLAS Life Sciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

SELLAS Life Sciences's market cap was $1.70B on Nov 11, 2026, against $202.63M a year earlier. Over the last 5 years it ranged from $18.17M to $2.69B, with a median of $74.50M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.70B+260.5%
2025Dec 31, 2025$471.55M+604.2%
2024Dec 31, 2024$66.96M+122.5%
2023Dec 29, 2023$30.10M-38.1%
2022Dec 30, 2022$48.59M-44.7%
2021Dec 31, 2021$87.78M+59.7%
2020Dec 31, 2020$54.97M+181.0%
2019Dec 31, 2019$19.56M-22.4%
2018Dec 31, 2018$25.22M-92.3%
2017Dec 29, 2017$328.71M-47.3%
2016Dec 30, 2016$624.26M-91.3%
2015Dec 31, 2015$7.17B+30.3%
2014Dec 31, 2014$5.50B-64.8%
2013Dec 31, 2013$15.61B+403.1%
2012Dec 31, 2012$3.10B+412.0%
2011Dec 30, 2011$606.09M–

More SELLAS Life Sciences figures

See a number that looks wrong?